Header Logo

Connection

David Bennett to Amyloid beta-Peptides

Back to Details
This is a "connection" page, showing publications David Bennett has written about Amyloid beta-Peptides.
David Bennett
Connection Strength
8.895
Amyloid beta-Peptides
  1. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.569
  2. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016 Feb; 30(2):135-42.
    View in: PubMed
    Score: 0.449
  3. Alzheimer's disease: Unique markers for diagnosis & new treatment modalities. Indian J Med Res. 2015 Oct; 142(4):369-82.
    View in: PubMed
    Score: 0.439
  4. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.438
  5. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.382
  6. Amyloid pathology in persons with "normal" cognition. Neurology. 2012 Jan 24; 78(4):228-9.
    View in: PubMed
    Score: 0.338
  7. Brain ?-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023 02 24; 78(2):277-285.
    View in: PubMed
    Score: 0.183
  8. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.182
  9. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia. J Alzheimers Dis. 2023; 96(2):563-578.
    View in: PubMed
    Score: 0.181
  10. Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition. J Neuroinflammation. 2021 Jul 04; 18(1):147.
    View in: PubMed
    Score: 0.163
  11. Association of Amyloid-? Pathology with Decision Making and Scam Susceptibility. J Alzheimers Dis. 2021; 83(2):879-887.
    View in: PubMed
    Score: 0.158
  12. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.147
  13. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
    View in: PubMed
    Score: 0.145
  14. Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in A? and TAU proteostasis. Hum Mol Genet. 2019 03 01; 28(5):718-735.
    View in: PubMed
    Score: 0.139
  15. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A?, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430.
    View in: PubMed
    Score: 0.139
  16. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease. Acta Neuropathol. 2019 05; 137(5):801-823.
    View in: PubMed
    Score: 0.138
  17. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.136
  18. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.133
  19. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.133
  20. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's A?42, Tau, TREM2, and TYROBP in Drosophila models. Genome Med. 2018 03 29; 10(1):26.
    View in: PubMed
    Score: 0.130
  21. A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci. 2018 01 31; 38(5):1085-1099.
    View in: PubMed
    Score: 0.128
  22. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of?Selective Neuronal Vulnerability. Stem Cell Reports. 2017 12 12; 9(6):1868-1884.
    View in: PubMed
    Score: 0.127
  23. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.121
  24. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.117
  25. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 02; 87(5):539-47.
    View in: PubMed
    Score: 0.116
  26. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry. 2017 02; 22(2):287-295.
    View in: PubMed
    Score: 0.113
  27. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Mol Neurobiol. 2016 10; 53(8):5066-78.
    View in: PubMed
    Score: 0.109
  28. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.099
  29. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.097
  30. Elevated A?42 in aged, non-demented individuals with cerebral atherosclerosis. Curr Alzheimer Res. 2013 Oct; 10(8):785-9.
    View in: PubMed
    Score: 0.095
  31. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
    View in: PubMed
    Score: 0.095
  32. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.094
  33. PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
    View in: PubMed
    Score: 0.094
  34. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.093
  35. Brain amyloid-? oligomers in ageing and Alzheimer's disease. Brain. 2013 May; 136(Pt 5):1383-98.
    View in: PubMed
    Score: 0.092
  36. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.090
  37. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.089
  38. Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
    View in: PubMed
    Score: 0.085
  39. Functional links between A? toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science. 2011 Dec 02; 334(6060):1241-5.
    View in: PubMed
    Score: 0.084
  40. ELISA measurement of specific non-antigen-bound antibodies to A?1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects. J Neuroinflammation. 2011 Aug 09; 8:93.
    View in: PubMed
    Score: 0.082
  41. Antemortem amyloid imaging and ?-amyloid pathology in a case with dementia with Lewy bodies. Neurobiol Aging. 2012 May; 33(5):878-85.
    View in: PubMed
    Score: 0.078
  42. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron. 2008 Dec 26; 60(6):988-1009.
    View in: PubMed
    Score: 0.069
  43. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
    View in: PubMed
    Score: 0.064
  44. Immunization therapy for Alzheimer disease? Neurology. 2005 Jan 11; 64(1):10-2.
    View in: PubMed
    Score: 0.052
  45. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.
    View in: PubMed
    Score: 0.048
  46. High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies. J Neuropathol Exp Neurol. 2023 Nov 20; 82(12):976-986.
    View in: PubMed
    Score: 0.048
  47. Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023 08 01; 146(8):3192-3205.
    View in: PubMed
    Score: 0.047
  48. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.046
  49. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.046
  50. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.043
  51. Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia. J Gerontol A Biol Sci Med Sci. 2022 04 01; 77(4):664-672.
    View in: PubMed
    Score: 0.043
  52. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
    View in: PubMed
    Score: 0.043
  53. Identification of the A?37/42 peptide ratio in CSF as an improved A? biomarker for Alzheimer's disease. Alzheimers Dement. 2023 01; 19(1):79-96.
    View in: PubMed
    Score: 0.043
  54. Association of small vessel disease with tau pathology. Acta Neuropathol. 2022 03; 143(3):349-362.
    View in: PubMed
    Score: 0.042
  55. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.042
  56. Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance. Alzheimers Dement. 2022 10; 18(10):1797-1811.
    View in: PubMed
    Score: 0.042
  57. Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain. Mol Neurodegener. 2021 11 06; 16(1):75.
    View in: PubMed
    Score: 0.042
  58. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. Neurobiol Dis. 2021 12; 161:105542.
    View in: PubMed
    Score: 0.042
  59. BMI1 is associated with CS8F amyloid-? and rates of cognitive decline in Alzheimer's disease. Alzheimers Res Ther. 2021 10 05; 13(1):164.
    View in: PubMed
    Score: 0.042
  60. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron. 2021 11 03; 109(21):3402-3420.e9.
    View in: PubMed
    Score: 0.041
  61. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
    View in: PubMed
    Score: 0.040
  62. Enhancing Top-Down Proteomics of Brain Tissue with FAIMS. J Proteome Res. 2021 05 07; 20(5):2780-2795.
    View in: PubMed
    Score: 0.040
  63. Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer's disease. Transl Psychiatry. 2021 02 24; 11(1):139.
    View in: PubMed
    Score: 0.040
  64. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.040
  65. Bayesian Genome-wide TWAS Method to Leverage both cis- and trans-eQTL Information through Summary Statistics. Am J Hum Genet. 2020 10 01; 107(4):714-726.
    View in: PubMed
    Score: 0.039
  66. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.
    View in: PubMed
    Score: 0.038
  67. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020 06; 26(6):952-963.
    View in: PubMed
    Score: 0.038
  68. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. Neurobiol Aging. 2020 09; 93:61-68.
    View in: PubMed
    Score: 0.038
  69. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.037
  70. Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019 09 01; 142(9):2581-2589.
    View in: PubMed
    Score: 0.036
  71. Neuropsychological latent classes at enrollment and postmortem neuropathology. Alzheimers Dement. 2019 09; 15(9):1195-1207.
    View in: PubMed
    Score: 0.036
  72. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999 Aug; 158(2):469-90.
    View in: PubMed
    Score: 0.036
  73. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.036
  74. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.034
  75. DNA methylation variability in Alzheimer's disease. Neurobiol Aging. 2019 04; 76:35-44.
    View in: PubMed
    Score: 0.034
  76. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains. Nat Neurosci. 2019 01; 22(1):37-46.
    View in: PubMed
    Score: 0.034
  77. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects. Sci Rep. 2018 09 03; 8(1):13119.
    View in: PubMed
    Score: 0.034
  78. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.033
  79. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.033
  80. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018 06; 21(6):811-819.
    View in: PubMed
    Score: 0.033
  81. Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiol Aging. 2018 02; 62:243.e7-243.e14.
    View in: PubMed
    Score: 0.032
  82. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging. 2018 01; 61:138-145.
    View in: PubMed
    Score: 0.031
  83. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.031
  84. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Mol Psychiatry. 2018 06; 23(6):1521-1529.
    View in: PubMed
    Score: 0.030
  85. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. J Neuropathol Exp Neurol. 2017 Feb 01; 76(2):70-88.
    View in: PubMed
    Score: 0.030
  86. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment. Acta Neuropathol Commun. 2016 12 08; 4(1):127.
    View in: PubMed
    Score: 0.030
  87. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
    View in: PubMed
    Score: 0.025
  88. REST and stress resistance in ageing and Alzheimer's disease. Nature. 2014 03 27; 507(7493):448-54.
    View in: PubMed
    Score: 0.025
  89. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging. 1993 Nov-Dec; 14(6):589-96.
    View in: PubMed
    Score: 0.024
  90. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.023
  91. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.
    View in: PubMed
    Score: 0.023
  92. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.022
  93. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011 Sep; 70(9):788-98.
    View in: PubMed
    Score: 0.021
  94. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608.
    View in: PubMed
    Score: 0.020
  95. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem. 2010 Oct; 115(1):47-57.
    View in: PubMed
    Score: 0.019
  96. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009 Jan; 68(1):48-58.
    View in: PubMed
    Score: 0.017
  97. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci. 2007 Oct 03; 27(40):10810-7.
    View in: PubMed
    Score: 0.016
  98. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 Apr; 170(4):1200-9.
    View in: PubMed
    Score: 0.015
  99. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Acta Neuropathol. 2005 Aug; 110(2):135-44.
    View in: PubMed
    Score: 0.013
  100. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. Am J Pathol. 2003 Oct; 163(4):1615-21.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.